Category:Otolaryngology: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 432: | Line 432: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |Chapters | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | ||
| Line 441: | Line 439: | ||
|- | |- | ||
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Otolaryngology | | rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Otolaryngology | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |[[Acute viral nasopharyngitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 449: | Line 445: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 457: | Line 451: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 466: | Line 458: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 474: | Line 464: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 483: | Line 471: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 492: | Line 478: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 501: | Line 485: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 510: | Line 492: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 519: | Line 499: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 528: | Line 506: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 537: | Line 513: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 546: | Line 520: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 555: | Line 527: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 564: | Line 534: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 573: | Line 541: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 582: | Line 548: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 591: | Line 555: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 600: | Line 562: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 609: | Line 569: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 618: | Line 576: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 627: | Line 583: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Revision as of 14:38, 24 June 2020
List of Chapters Requiring Content
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Otolaryngology | |||||||
In progress chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Otolaryngology | |||||||
Completed chapters
| Category | Chapters | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|
| Otolaryngology | Acute viral nasopharyngitis | ||||
Subcategories
This category has the following 9 subcategories, out of 9 total.
Pages in category "Otolaryngology"
The following 200 pages are in this category, out of 1,904 total.
(previous page) (next page)A
- Abscess
- Achalasia
- Achalasia (patient information)
- Achalasia causes
- Achalasia classification
- Achalasia CT
- Achalasia differential diagnosis
- Achalasia epidemiology and demographics
- Achalasia historical perspective
- Achalasia history and symptoms
- Achalasia laboratory findings
- Achalasia medical therapy
- Achalasia MRI
- Achalasia natural history, complications and prognosis
- Achalasia other diagnostic studies
- Achalasia other imaging findings
- Achalasia overview
- Achalasia pathophysiology
- Achalasia physical examination
- Achalasia primary prevention
- Achalasia risk factors
- Achalasia screening
- Achalasia secondary prevention
- Achalasia surgery
- Achalasia ultrasound
- Achalasia x ray
- Acinic cell carcinoma
- Acinic cell carcinoma (patient information)
- Acinic cell carcinoma case study one
- Acinic cell carcinoma cost-effectiveness of therapy
- Acinic cell carcinoma future or investigational therapies
- Acinic cell carcinoma other diagnostic studies
- Acinic cell carcinoma other imaging findings
- Acinic cell carcinoma overview
- Acinic cell carcinoma physical examination
- Acinic cell carcinoma x ray
- Acoustic neuroma
- Acoustic neuroma (patient information)
- Acoustic neuroma case study one
- Acoustic neuroma causes
- Acoustic neuroma chest x ray
- Acoustic neuroma classification
- Acoustic neuroma cost-effectiveness of therapy
- Acoustic neuroma CT
- Acoustic neuroma differential diagnosis
- Acoustic neuroma echocardiography or ultrasound
- Acoustic neuroma electrocardiogram
- Acoustic neuroma epidemiology and demographics
- Acoustic neuroma future or investigational therapies
- Acoustic neuroma historical perspective
- Acoustic neuroma history and symptoms
- Acoustic neuroma laboratory findings
- Acoustic neuroma medical therapy
- Acoustic neuroma MRI
- Acoustic neuroma natural history, complications & prognosis
- Acoustic neuroma other diagnostic studies
- Acoustic neuroma other imaging findings
- Acoustic neuroma pathophysiology
- Acoustic neuroma physical examination
- Acoustic neuroma primary prevention
- Acoustic neuroma risk factors
- Acoustic neuroma screening
- Acoustic neuroma secondary prevention
- Acoustic neuroma surgery
- Acoustic neuroma x-ray
- Actinomyces (patient information)
- Actinomycosis (patient information)
- Acute upper airway obstruction (patient information)
- Acute viral nasopharyngitis (common cold)
- Acute viral nasopharyngitis (patient information)
- Acute viral nasopharyngitis case study one
- Acute viral nasopharyngitis causes
- Acute viral nasopharyngitis classification
- Acute viral nasopharyngitis cost-effectiveness of therapy
- Acute viral nasopharyngitis CT
- Acute viral nasopharyngitis epidemiology and demographics
- Acute viral nasopharyngitis future or investigational therapies
- Acute viral nasopharyngitis historical perspective
- Acute viral nasopharyngitis history and symptoms
- Acute viral nasopharyngitis laboratory findings
- Acute viral nasopharyngitis medical therapy
- Acute viral nasopharyngitis MRI
- Acute viral nasopharyngitis other diagnostic studies
- Acute viral nasopharyngitis other imaging findings
- Acute viral nasopharyngitis overview
- Acute viral nasopharyngitis pathophysiology
- Acute viral nasopharyngitis physical examination
- Acute viral nasopharyngitis primary prevention
- Acute viral nasopharyngitis risk factors
- Acute viral nasopharyngitis secondary prevention
- Acute viral nasopharyngitis surgey
- Acute viral nasopharyngitis ultrasound
- Acute viral nasopharyngitis X ray
- Adenoiditis
- Adenoiditis (patient information)
- Adenoiditis causes
- Adenoiditis classification
- Adenoiditis cost-effectiveness of therapy
- Adenoiditis CT
- Adenoiditis diagnostic criteria
- Adenoiditis differential diagnosis
- Adenoiditis epidemiology and demographics
- Adenoiditis future or investigational therapies
- Adenoiditis historical perspective
- Adenoiditis history and symptoms
- Adenoiditis laboratory findings
- Adenoiditis medical therapy
- Adenoiditis MRI
- Adenoiditis natural history, complications and prognosis
- Adenoiditis other diagnostic studies
- Adenoiditis other imaging findings
- Adenoiditis overview
- Adenoiditis pathophysiology
- Adenoiditis physical examination
- Adenoiditis primary prevention
- Adenoiditis risk factors
- Adenoiditis screening
- Adenoiditis secondary prevention
- Adenoiditis surgery
- Adenoiditis x ray
- Airway obstruction (patient information)
- Allergy
- Allergy (patient information)
- Allergy case study one
- Allergy causes
- Allergy chest x ray
- Allergy classification
- Allergy CT
- Allergy echocardiography or ultrasound
- Allergy epidemiology and demographics
- Allergy historical perspective
- Allergy history and symptoms
- Allergy laboratory findings
- Allergy medical therapy
- Allergy MRI
- Allergy natural history, complications and prognosis
- Allergy other diagnostic studies
- Allergy other imaging findings
- Allergy overview
- Allergy pathophysiology
- Allergy physical examination
- Allergy primary prevention
- Allergy risk factors
- Allergy screening
- Allergy secondary prevention
- Ameloblastoma
- Ameloblastoma case study one
- Ameloblastoma causes
- Ameloblastoma classification
- Ameloblastoma cost-effectiveness of therapy
- Ameloblastoma CT
- Ameloblastoma differential diagnosis
- Ameloblastoma echocardiography and ultrasound
- Ameloblastoma epidemiology and demographics
- Ameloblastoma future or investigational therapies
- Ameloblastoma historical perspective
- Ameloblastoma history and symptoms
- Ameloblastoma laboratory findings
- Ameloblastoma medical therapy
- Ameloblastoma MRI
- Ameloblastoma natural history, complications and prognosis
- Ameloblastoma other diagnostic studies
- Ameloblastoma other imaging findings
- Ameloblastoma overview
- Ameloblastoma pathophysiology
- Ameloblastoma physical examination
- Ameloblastoma primary prevention
- Ameloblastoma risk factors
- Ameloblastoma screening
- Ameloblastoma secondary prevention
- Ameloblastoma surgery
- Ameloblastoma x ray
- Amelogenesis Imperfecta
- Amelogenesis imperfecta (patient information)
- American Academy of Otolaryngology
- Anaplastic thyroid cancer (patient information)
- Anaplastic thyroid cancer biopsy
- Anaplastic thyroid cancer causes
- Anaplastic thyroid cancer chest x ray
- Anaplastic thyroid cancer CT
- Anaplastic thyroid cancer differential diagnosis
- Anaplastic thyroid cancer echocardiography or ultrasound
- Anaplastic thyroid cancer epidemiology and demographics
- Anaplastic thyroid cancer historical perspective
- Anaplastic thyroid cancer history and symptoms
- Anaplastic thyroid cancer laboratory findings
- Anaplastic thyroid cancer medical therapy
- Anaplastic thyroid cancer MRI
- Anaplastic thyroid cancer natural history, complications and prognosis
- Anaplastic thyroid cancer other diagnostic studies
- Anaplastic thyroid cancer other imaging findings
- Anaplastic thyroid cancer overview
- Anaplastic thyroid cancer pathophysiology
- Anaplastic thyroid cancer physical examination
- Anaplastic thyroid cancer prevention
- Anaplastic thyroid cancer risk factors
- Anaplastic thyroid cancer staging
- Anaplastic thyroid cancer surgery